BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18671203)

  • 21. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Chen F; Dai Z; Kang Y; Lv G; Keller ET; Jiang Y
    Osteoporos Int; 2016 Apr; 27(4):1469-1476. PubMed ID: 26556733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate.
    Goodship AE; Blunn GW; Green J; Coathup MJ
    J Orthop Res; 2008 May; 26(5):693-703. PubMed ID: 18050308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bisphosphonates on osteoporosis: Focus on zoledronate.
    Oryan A; Sahvieh S
    Life Sci; 2021 Jan; 264():118681. PubMed ID: 33129881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronate reduces unwanted bone resorption in intercalary bone allografts.
    Seo SW; Cho SK; Storer SK; Lee FY
    Int Orthop; 2010 Apr; 34(4):599-603. PubMed ID: 19343345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
    Nakamura Y; Hayashi K; Abu-Ali S; Naito M; Fotovati A
    J Bone Joint Surg Am; 2008 Apr; 90(4):824-32. PubMed ID: 18381321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of zoledronate on markers of bone metabolism and subchondral bone mineral density in dogs with experimentally induced cruciate-deficient osteoarthritis.
    Agnello KA; Trumble TN; Chambers JN; Seewald W; Budsberg SC
    Am J Vet Res; 2005 Sep; 66(9):1487-95. PubMed ID: 16261820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
    Kurth AH; Eberhardt C; Müller S; Steinacker M; Schwarz M; Bauss F
    Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits.
    Li JP; Li P; Hu J; Dong W; Liao NN; Qi MC; Li JY
    J Periodontol; 2014 Feb; 85(2):308-16. PubMed ID: 23688100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN; Aref MW; Gupta A; McNerny EMB; Brown D; Wallace JM; Allen MR
    Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
    Miki T; Minamide T
    Clin Calcium; 2007 Jan; 17(1):18-22. PubMed ID: 17211089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local delivery of zoledronate from a poly (d,l-lactide)-coating increases fixation of hydroxy-coated implants.
    Jakobsen T; Bechtold JE; Søballe K; Jensen T; Vestermark MT; Baas J
    J Orthop Res; 2017 May; 35(5):974-979. PubMed ID: 26925986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The time-dependent effect of ibandronate on bone graft remodeling in an ovariectomized rat spinal arthrodesis model.
    Park SB; Park SH; Kang YK; Chung CK
    Spine J; 2014 Aug; 14(8):1748-57. PubMed ID: 24486470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local delivery of zoledronate from a poly (D,L-lactide)-Coating increases fixation of press-fit implants.
    Jakobsen T; Bechtold JE; Søballe K; Jensen T; Greiner S; Vestermark MT; Baas J
    J Orthop Res; 2016 Jan; 34(1):65-71. PubMed ID: 26177742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs.
    Hak DJ
    Injury; 2018 Aug; 49(8):1461-1465. PubMed ID: 29709376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
    Gao Y; Zou S; Liu X; Bao C; Hu J
    Biomaterials; 2009 Mar; 30(9):1790-6. PubMed ID: 19135249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.
    Abtahi J; Agholme F; Sandberg O; Aspenberg P
    J Dent Res; 2013 Mar; 92(3):279-83. PubMed ID: 23264610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bone Remodelling in the Proximal Femur after Uncemented Total Hip Arthroplasty in Patients with Osteoporosis].
    Lacko M; Schreierová D; Čellár R; Vaško G
    Acta Chir Orthop Traumatol Cech; 2015; 82(6):430-6. PubMed ID: 26787184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.